Thierry Chignon

Senior Partner - Mérieux Développement

Thierry Chignon is a Senior Partner in the investment vehicle of the Mérieux family. With 220M€ under management, Merieux Developpement actively invest in Health and Nutrition for both humans and animals, combining Venture and Growth investments, for both products and services.

Thierry has more than 25 years of experience in Quality Assurance, Regulatory Affairs, Clinical Trials with particular focus on the medical device sector, including a first operational experience as Head Pharmacist within Institut Mérieux (1988-1997, now Sanofi Pasteur).

Prior to Merieux Developpement, he was partner of Matignon Investissement et Gestion (2006-2014) to raise and deploy the first largest European fund dedicated to European medical technologies (Matignon Technologies II, 100M$). After several positive exits (trade sale and IPOs), Thierry joined as Senior Partner Merieux Développement in early 2014.

As Director with Quintiles Consulting Europe (1997-2006), he defined and participated in the implementation of business development strategies for innovative products in Europe (market access). Thierry also worked for 5 years as an Expert of the Commission of the European Union drafting Guidelines and Regulations for medical devices. He has chaired several standardization working groups in CEN and ISO (Risk Management), as well as a Eucomed Task Force on Tissue engineering.

Thierry holds a Pharmacy Degree, PharmD, a Master Degree from IEP Paris (Sciences Politiques Paris) and an executive MBA from HEC Paris.

 
prospective

Workshop
Digital health and innovation for sustainable healthcare


Tuesday April 4th from 03:30 pm to 06:00 pm
Workshop B

IC

Investor
Pitch session


Wednesday April 5th from 09:00 am to 11:00 am
Investor Room

 
IC

Investor
Pitch session


Wednesday April 5th from 02:30 pm to 04:30 pm
Investor Room

IC

Investor
Pitch session


Thursday April 6th from 09:00 am to 11:30 am
Investor Room

 
IC

Investor
Pitch session


Thursday April 6th from 02:00 pm to 03:30 pm
Investor Room